Explore the Renew MD product collection and get clear, product-specific information from our team.
TIRZEPATIDE
Disposable pen
Ref. RMD-001
Tirzepatide activates both GIP and GLP-1 receptors, which help regulate blood sugar and appetite. Approved prescription products can improve glucose control and reduce body weight by affecting insulin release, glucagon, food intake, and satiety. Approval applies to specific products and indications, so an unapproved or differently formulated product is not automatically equivalent.
NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme essential to energy-producing reactions and many redox processes. It also participates in pathways involved in DNA repair and cell signaling, and its metabolism is studied in aging and metabolic research. These biological roles do not prove that NAD+ products reverse aging or deliver clinical benefits; evidence depends on the product and route.
NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme essential to energy-producing reactions and many redox processes. It also participates in pathways involved in DNA repair and cell signaling, and its metabolism is studied in aging and metabolic research. These biological roles do not prove that NAD+ products reverse aging or deliver clinical benefits; evidence depends on the product and route.
GHK-Cu is a copper-binding tripeptide, also called copper tripeptide-1, studied for its interaction with skin and tissue-remodeling pathways. Laboratory and early research has examined collagen-related processes, extracellular-matrix remodeling, and wound-response signaling, which is why it appears in some cosmetic products. Evidence for clinical effects varies by formulation, and research findings do not prove that every product improves healing or skin appearance.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone that stimulates the pituitary gland to release growth hormone. This can raise IGF-1, and an FDA-approved prescription formulation is indicated to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. That approval is specific to the approved medicine and indication, not general weight loss or every tesamorelin formulation.
Meet the Renew MD sunscreen presentation, labeled SPF 50+ PA++++ in a 30 g format. Ask our team about ingredients, product documentation, directions, and availability.
GHK-Cu is a copper-binding tripeptide, also called copper tripeptide-1, studied for its interaction with skin and tissue-remodeling pathways. Laboratory and early research has examined collagen-related processes, extracellular-matrix remodeling, and wound-response signaling, which is why it appears in some cosmetic products. Evidence for clinical effects varies by formulation, and research findings do not prove that every product improves healing or skin appearance.
Single-serving shot · Fortified with CLA + Guarana
Ref. RMD-025
A convenient single-serving shot combining 3,000 mg of L-carnitine, 1,000 mg of CLA, and 100 mg of guarana extract (standardized to 20 mg of caffeine). L-carnitine plays a role in transporting fatty acids into mitochondria, where they are used for energy. Guarana provides a light caffeine boost. Designed to support energy, weight management, and well-being.* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Each scoop (10.2 g) provides 10 g of collagen peptides, 60 mg of L-tryptophan, and 125 mg of NMN (nicotinamide mononucleotide), a precursor to NAD+. Designed to support hair, skin, nails, joints, and connective tissue.* About 24 servings per 250 g container. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The Renew MD RETA disposable pen, 10 mg / 1 mL, for subcutaneous use and single patient use only. Contact our team for product information and availability.
Tirzepatide activates both GIP and GLP-1 receptors, which help regulate blood sugar and appetite. Approved prescription products can improve glucose control and reduce body weight by affecting insulin release, glucagon, food intake, and satiety. Approval applies to specific products and indications, so an unapproved or differently formulated product is not automatically equivalent.
MOTS-c is a short peptide encoded by mitochondrial DNA and studied as a signal between mitochondria and the rest of the cell. Preclinical studies have explored its possible roles in metabolic regulation, insulin sensitivity, and responses to exercise or cellular stress. These findings remain investigational, with limited reliable evidence of benefit and safety in humans.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone that stimulates the pituitary gland to release growth hormone. This can raise IGF-1, and an FDA-approved prescription formulation is indicated to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. That approval is specific to the approved medicine and indication, not general weight loss or every tesamorelin formulation.
GHK-Cu is a copper-binding tripeptide, also called copper tripeptide-1, studied for its interaction with skin and tissue-remodeling pathways. Laboratory and early research has examined collagen-related processes, extracellular-matrix remodeling, and wound-response signaling, which is why it appears in some cosmetic products. Evidence for clinical effects varies by formulation, and research findings do not prove that every product improves healing or skin appearance.
BPC-157 is a synthetic 15-amino-acid peptide, while TB-500 is a name commonly used for a thymosin-beta-4-related peptide fragment. Preclinical studies have explored tissue repair, cell migration, inflammation, and blood-vessel-related pathways, but most evidence comes from laboratory or animal research. This combination has not been established as a safe and effective human treatment through robust clinical trials, and a product’s contents and quality require independent verification.
AOD-9604 is a modified fragment of human growth hormone that was investigated for possible effects on fat metabolism. Research examined whether it might influence fat breakdown without the full growth-promoting effects of growth hormone, but results have not established reliable clinical benefit for weight management. It is not an FDA-approved weight-loss medicine, so effectiveness claims remain unproven.
NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme essential to energy-producing reactions and many redox processes. It also participates in pathways involved in DNA repair and cell signaling, and its metabolism is studied in aging and metabolic research. These biological roles do not prove that NAD+ products reverse aging or deliver clinical benefits; evidence depends on the product and route.
Semaglutide is a GLP-1 receptor agonist that mimics a gut hormone involved in glucose regulation and appetite. Approved prescription formulations can improve blood-sugar control and, for specific indications, support chronic weight management by increasing satiety, reducing appetite, and affecting gastric emptying. Approval and dosing are product- and indication-specific, so research-labeled or unapproved formulations should not be assumed to match approved medicines.
L-carnitine is a naturally occurring compound that helps transport long-chain fatty acids into mitochondria for energy production. The body makes it and people also obtain it from food; prescription carnitine is used for certain documented deficiencies. It should not be assumed that every supplement or injectable product reliably causes fat loss or improves athletic performance in people without a relevant deficiency.
5-Amino-1MQ is a small-molecule research compound—not a peptide—studied for inhibition of nicotinamide N-methyltransferase (NNMT). Cell and animal research has investigated NNMT inhibition for possible effects on cellular metabolism and fat-related pathways. Human clinical evidence establishing its safety, dose, or effectiveness for weight loss or other health outcomes is not established.
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH) and has been investigated mainly in Russia and nearby countries. Research has explored possible effects on neurotrophic signaling and cognitive or neurological outcomes, but clinical evidence is limited in quality and generalizability. It is not FDA-approved in the United States, and claims about memory, focus, or neuroprotection are not established outcomes.
KPV is a three-amino-acid peptide made of lysine, proline, and valine, derived from the C-terminal region of alpha-melanocyte-stimulating hormone. Laboratory and animal studies have investigated possible anti-inflammatory activity, including in models of intestinal and skin inflammation. Human evidence is insufficient to establish clinical effectiveness, safe dosing, or safety across oral, topical, or injectable formulations.
SS-31, also called elamipretide, is a mitochondria-targeting tetrapeptide studied for its interaction with cardiolipin in the inner mitochondrial membrane. Research has examined whether it may support mitochondrial membrane function and cellular energy processes in certain disease settings. Evidence and regulatory status depend on the specific indication and product; research formulations should not be assumed to be approved or interchangeable with studied medicines.
Oxytocin is a naturally occurring hormone and neuropeptide involved in childbirth, milk ejection, and aspects of social and reproductive physiology. Prescription oxytocin has established obstetric uses, while research into social behavior and emotional processing has produced mixed, context-dependent findings. These findings do not establish that nonstandard products or unapproved routes, including nasal formulations, are safe or effective for general wellness.
Targeted Body Contouring & Skin Refinement
LIPO REDUX is an innovative body-contouring formulation developed to support a smoother, firmer, and more sculpted appearance. Designed with targeted aesthetic goals in mind, LIPO REDUX may help improve the appearance of stubborn areas of localized fullness while promoting more refined body contours.
Its specialized approach focuses on areas commonly associated with unwanted fullness, uneven skin texture, and the visible appearance of cellulite.
Potential Benefits:
• Body Contouring: May help promote a more defined and sculpted silhouette.
• Localized Fullness: May support aesthetic goals in areas where stubborn fullness is most noticeable.
• Cellulite Appearance: May help improve the look of uneven or dimpled skin.
• Skin Firmness: May promote a smoother, firmer, and more toned appearance.
• Targeted Refinement: Designed for contour-focused applications involving the abdomen, waist, hips, thighs, and upper arms.
A More Refined Silhouette
LIPO REDUX brings a targeted approach to body aesthetics, focusing on the appearance of smoother contours, improved skin texture, and natural-looking definition.
Product information and availability must be confirmed individually. Packaging is shown as supplied and is not proof of regulatory authorization. This website does not provide prescribing, dosing, or treatment recommendations.
Our commitment
Quality. Clarity. Responsible innovation.
We believe product decisions should be guided by appropriate testing, reliable sourcing, transparent information, and applicable quality standards.